Results 141 to 150 of about 555,884 (236)

Use of Medicines by Community Dwelling Elderly in Ontario [PDF]

OBJECTIVE: Prescription medicine use by the elderly is of growing concern as indicated by a large literature focused on rising costs, patient compliance and the appropriateness of use.
J. Charles Victor, Joan A. Marshman, Peri J. Ballantyne, Philippa J. Clarke   +3 more
core  

How to balance valuable innovation with affordable access to medicines in Belgium? [PDF]

Front Pharmacol, 2022
Simoens S, Abdallah K, Barbier L, Lacosta TB, Blonda A, Car E, Claessens Z, Desmet T, De Sutter E, Govaerts L, Janssens R, Lalova T, Moorkens E, Saesen R, Schoefs E, Vandenplas Y, Van Overbeeke E, Verbaanderd C, Huys I.   +18 more
europepmc   +1 more source

India's product patent protection regime: Less or more of "pills for the poor"? [PDF]

The year 2005 marks the end of transition period for many developing countries with competent pharmaceutical sectors that competed in supplying generic versions of patented drugs to LDCs before, thereby inducing price competition and enhancing access to ...
Gehl Sampath, Padmashree
core  

TRIPS flexibilities help change policy and practice to increase access to medicines: evidence from 2001 to 2024. [PDF]

BMJ Glob Health
Dunn M, 't Hoen E, Boulet P, Mara K, Perehudoff K.   +4 more
europepmc   +1 more source

Improving access to medicines and beyond: the national volume-based procurement policy in China. [PDF]

BMJ Glob Health, 2023
Zhu Z, Wang Q, Sun Q, Lexchin J, Yang L.
europepmc   +1 more source

The UK early access to medicines scheme: uptake, approvals, and reimbursement. [PDF]

Int J Technol Assess Health Care
Brewer CF.
europepmc   +1 more source

Community pharmacists' views about prescription medicine co-payments and potential implications for equitable access to medicines: a critical realist interpretation. [PDF]

J Pharm Policy Pract, 2023
Peacocke EF, Fusheini A, Norris P.
europepmc   +1 more source

SDG indicator 3.b.3 - an analysis of its robustness and challenges for measuring access to medicines for children. [PDF]

BMC Health Serv Res, 2023
Joosse IR, Wirtz VJ, van Mourik AT, Wagner BA, Mantel-Teeuwisse AK, Suleman F, van den Ham HA.   +6 more
europepmc   +1 more source

Global 'side effects' of the EU's pharmaceutical reforms and their impact on access to medicines in LMICs. [PDF]

BMJ Glob Health
Perehudoff K.
europepmc   +1 more source

Initiatives to promote access to medicines after publication of the Brazilian Policy on the Comprehensive Care of People with Rare Diseases. [PDF]

Orphanet J Rare Dis, 2023
Cunico C, Vicente G, Leite SN.
europepmc   +1 more source